{
    "organizations": [],
    "uuid": "ca1fec380d26a9725d3e57d57bfcfed2341c0093",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hunan-er-kang-pharmaceutical-says/brief-hunan-er-kang-pharmaceutical-says-being-probed-by-securities-regulator-idUSL3N1S36IK",
    "ord_in_thread": 0,
    "title": "Hunan Er-Kang Pharmaceutical Says Being Probed By Securities Regulator",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Hunan Er-Kang Pharmaceutical Co Ltd :\n* SAYS IT IS BEING INVESTIGATED BY SECURITIES REGULATOR FOR POSSIBLE VIOLATION OF SECURITIES REGULATIONS Source text in Chinese: bit.ly/2HsNsjf (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-04-26T21:22:00.000+03:00",
    "crawled": "2018-04-27T16:32:45.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "hunan",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "investigated",
        "security",
        "regulator",
        "possible",
        "violation",
        "security",
        "regulation",
        "source",
        "text",
        "chinese",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}